Impact of respiratory syncytial virus infection and palivizumab on severe acute lower respiratory infection during the first 6 months of life in a cohort of Colombian infants. Source: International Congress 2018 – Clinical problems in paediatric pulmonology Year: 2018
Eosinopenia in COPD patients with severe acute respiratory virus 2 (Sars-CoV-2) infection as a potential fatal outcome predictor Source: Virtual Congress 2021 – COVID-19 and obstructive diseases: risk factors, management and long-term effects Year: 2021
Prospective study on the contribution of respiratory syncytial virus (RSV) to acute lower respiratory tract infections (ALRTI) in young hospitalised children Source: Eur Respir J 2004; 24: Suppl. 48, 622s Year: 2004
Respiratory syncitial virus infection in hospitalized Brazilian infants with acute lower respiratory disease: incidence and associated factors Source: Eur Respir J 2005; 26: Suppl. 49, 628s Year: 2005
Early identification of patients at risk for acute respiratory distress syndrome among severe pneumonia: a retrospective cohort study Source: International Congress 2018 – Critically ill patients: prognostic factors and biomarkers Year: 2018
Effect of dexamethasone on acute respiratory distress syndrome induced by the H5N1 virus in mice Source: Eur Respir J 2009; 33: 852-860 Year: 2009
Palivizumab: Is it cost effective to extend the vaccination period for patients at risk of severe respiratory syncytial virus infection? Source: Virtual Congress 2021 – Acute and chronic lung infections in children Year: 2021
Peculiarities of an ARDS and respiratory support in patients with severe viral (H1N1) pneumonia Source: Annual Congress 2012 - Infections and sepsis in the ICU Year: 2012
Monozygotic twins discordant for severe respiratory syncytial virus infection in infancy: clinical long-term follow-up of asthma prevalence, lung function and sensitization Source: Eur Respir J 2007; 30: Suppl. 51, 711s Year: 2007
Mortality among patients admitted for viral lower respiratory tract infections – a seasonal cohort study Source: International Congress 2019 – Clinical challenges in respiratory infection Year: 2019
Predictors of pneumonia in lower respiratory tract infections: 3C prospective cough complication cohort study Source: Eur Respir J, 50 (5) 1700434; 10.1183/13993003.00434-2017 Year: 2017
Oral presentation: The long-term effect of neonatal respiratory syncytial virus (RSV) infection on the response to adult allergen challenge Source: Lung Science Conference 2013 - Early origins and mechanisms of chronic lung disease Year: 2013
Respiratory syncytial virus infection in childcare and hospitalized children with different respiratory disease severity Source: Annual Congress 2006 - Virus-induced respiratory tract infection Year: 2006
Impaired ventilation is not independently associated with 28-day mortality in coronavirus disease 2019 (COVID-19) acute respiratory distress syndrome (ARDS) Source: Virtual Congress 2021 – COVID-19 acute respiratory distress syndrome Year: 2021
Palivizumab prophylaxis, respiratory syncytial virus and subsequent recurrent wheezing: a 2-year follow-up study Source: Eur Respir J 2006; 28: Suppl. 50, 758s Year: 2006
Radiological findings and correlation to clinical outcome in patients admitted due to influenza A (H1N1) infection Source: Annual Congress 2013 –Viral infections Year: 2013
Incidence of respiratory syncytial virus (RSV) positivity in young Italian children referred to the emergency departments for lower respiratory tract infection (LRTI) over two consecutive epidemic seasons Source: Eur Respir J 2004; 24: Suppl. 48, 622s Year: 2004
Premorbid lung function, respiratory syncytial virus infection and chronic respiratory morbidity in prematurely born infants Source: Annual Congress 2005 - Pulmonary function outcome, respiratory morbidity in prematurely born children and acute lung injury Year: 2005
Varicella-Zoster virus pneumonia in an adult population. Has the mortality decreased? Source: Annual Congress 2010 - Unusual pathogens in respiratory infections Year: 2010